Arrowhead Research Corporation
 
insert therapeutics unidym tego bio sciences science research anti-cancer drugs RNAi therapeutics carbon-based electronics nanotechnology arrowhead pasadena california nasdaq arwr
nanotechnology arrowhead pasadena california nasdaq arwr nanotechnology arrowhead pasadena california nasdaq arwr nanotechnology arrowhead pasadena california nasdaq arwr compound semiconductor materials nano particles laboratory

Scientific Advisory Board

Dr. Mauro Ferrari serves as a Professor & Director, Center for NanoMedicine, Brown Foundation Institute of Molecular Medicine, Chairman, Department of Biomedical Engineering, University of Texas Health Science Center at Houston, Professor of Experimental Therapeutics, University of Texas M.D. Anderson Cancer Center, Professor of Bioengineering, Rice University, and President of the Alliance for NanoHealth, Houston TX. Dr. Ferrari received a Ph.D. in Mechanical Engineering from U.C. Berkeley. Dr. Ferrari is a founder of biomedical nano/micro-technology in biomedical applications with more than 160 peer-reviewed journal articles, six books, more than 20 issued patents and about thirty more pending in the US and internationally. His career research and development portfolio totals over $50 million. Dr. Ferrari served as Special Expert on Nanotechnology at the National Cancer Institute in 2003-2005, providing leadership into the establishment of the NCI's Alliance for Nanotechnology.

Dr. Chad Mirkin has been recognized for his accomplishments with over 50 national and international Awards. These include a iCON Innovator of the Year Award (2007), NIH Director’s Pioneer Award, the Collegiate Inventors Award (2002, 2004), an Honorary Doctorate Degree from Dickinson College, the Pennsylvania State University Outstanding Science Alumni Award, the ACS Nobel Laureate Signature Award for Graduate Education in Chemistry, a Dickinson College Metzger-Conway Fellowship, the 2003 Raymond and Beverly Sackler Prize in the Physical Sciences, the Feynman Prize in Nanotechnology, the Leo Hendrick Baekeland Award, Crain’s Chicago Business “40 under 40 Award,” the Discover 2000 Award for Technological Innovation, I-Street Magazine’s Top 5 List for Leading Academics in Technology, the Materials Research Society Young Investigator Award, the ACS Award in Pure Chemistry, the PLU Fresenius Award, the Harvard University E. Bright Wilson Prize, the BF Goodrich Collegiate Inventors Award, the Camille Dreyfus Teacher-Scholar Award, the Alfred P. Sloan Foundation Award, the DuPont Young Professor Award, the NSF Young Investigator Award, the Naval Young Investigator Award, the Beckman Young Investigator Award, and the Dreyfus Foundation New Faculty Award.

He is a Fellow of the American Association for the Advancement of Science and has served on the Editorial Advisory Boards of over twenty scholarly journals. At present he is a member of the Editorial Advisory Boards of Accounts of Chemical Research, Advanced Materials, Angewandte Chemie, BioMacromolecules, Macromolecular Bioscience, SENSORS, Encyclopedia of Nanoscience and Nanotechnology, Chemistry-A European Journal, Chemistry & Biology, Nanotechnology Law & Business, The Scientist, Journal of Materials Chemistry, and Journal of Cluster Science, Plasmonics. Dr. Mirkin is the founding editor of the journal Small, one of the premier international nanotechnology journals, and he has co–edited two bestselling books on the field of nanobiotechnology.

Dr. Mirkin holds a B.S. degree from Dickinson College (1986, elected into Phi Beta Kappa) and a Ph.D. degree in chemistry from the Pennsylvania State University (1989). He was an NSF Postdoctoral Fellow at the Massachusetts Institute of Technology prior to becoming a chemistry professor at Northwestern University in 1991.

Thomas A. Tombrello, Ph.D. is the Chairman of the Division of Physics, Mathematics, and Astronomy at the California Institute of Technology and is the William R. Kenan, Jr. Professor of Physics. He has served as Caltech's Technology Assessment Officer since 1996. In this role, Dr. Tombrello is responsible for identifying and evaluating new and promising technologies for the Institute. From 1987 to 1989, Dr. Tombrello was Vice President and Director of Research at Schlumberger-Doll Research.

Among his many honors, Dr. Tombrello is a fellow of the American Physical Society. His research has primarily focused on applications of nuclear and ion beam physics to problems in materials science, geochemistry, and technology. Dr. Tombrello earned his B.A., M.A. and Ph.D. degrees in Physics at Rice University in Houston.

Mark Davis, Ph.D. is the Warren and Katharine Schlinger Professor of Chemical Engineering and Executive Officer of Chemical Engineering at California Institute of Technology. The founder of Insert Therapeutics, Inc. and Calando Pharmaceuticals, Inc., Dr. Davis is a Member of the National Academy of Engineering and a recipient of numerous awards including the prestigious Alan T. Waterman Award, given by the National Science Foundation annually to only one scientist in the United States across all disciplines. Dr. Davis was the first engineer to win this award for his work in rationally designed materials. Dr. Davis earned his B.S., M.S. and Ph.D. degrees in Chemical Engineering and holds over 25 patents, has published more than 250 papers and has presented over 400 seminars throughout the world.